Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust and a Clinical Senior Lecturer at the National Heart and Lung Institute within Imperial College London. She is a clinical trialist with expertise in stable coronary artery disease, coronary intervention, invasive physiology and invasive intravascular imaging. She leads a research group with a focus on clinical trials that impact the care of patients with cardiovascular disease. She believes in rigorous testing of clinical practice and the use of evidence-based medicine in all aspects of medical care. She designed, conducted and led ORBITA, the first randomised placebo-controlled trial of coronary angioplasty, published in The Lancet. She has over 100 peer-reviewed publications and a h-index of 31. She is a deputy editor at EuroIntervention and an associate editor at the European Heart Journal. She is the NIHR CRN North West London Cardiovascular speciality lead and co-head of the cardiovascular theme of the Imperial Biomedical Research Centre. She is Phase 1c lead for clinical medicine at Imperial College London. She is actively involved in the development and recruitment for many multi-centre international clinical trials.